Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00366977 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Cost of State Quitline Policies
A Phase 3 study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 3
- Development phase
- 4,614
- Enrollment target
NCT00366977: Completed Phase 3 study, sponsored by Kaiser Permanente.
NCT00366977 is a Phase 3 study that has completed, run by Kaiser Permanente. The registered enrollment target is 4,614 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (498% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00366977, a Phase 3 study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 4,614 participants
- Enrollment target
Study Summary
State-sponsored anti-tobacco campaigns are motivating large numbers of smokers to seek advice, assistance, and support to make their cessation efforts more successful. Like many states, Oregon has sponsored the implementation of a statewide telephone quitline to provide information, referrals, and cessation support for callers. This study will answer key policy questions about how to most effectively support smokers who call the Oregon Quitline for assistance. The specific aims are to recruit 4,500 callers to participate in a 3 x 2 randomized trial comparing the cost and cost effectiveness of three levels of behavioral intervention. We will also test two different policies on the availability of nicotine patch therapy. Subjects will be interviewed by telephone at 6 and 12 months to assess smoking status, quit attempts, and use of health plan anc community cessation services. Costs will be assessed separately from the perspectives of the patients, health plans, the State (i.e., Oregon Quitline), and society. Cost per quit and cost per year quality-adjusted years of life saved will be calculated from each of these perspectives.
Interventions
- BEHAVIORAL Multi-session telephone counseling
- DRUG NRT patches
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,614 participants |
| Start Date | 2000-06 |
| Est. Completion | 2005-01 |
| Phase | Phase 3 |
What the finished NCT00366977 record still lists
NCT00366977 is an interventional study that assigns participants to a tested intervention. Its 4,614 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (498% higher).
The record links to 0 conditions, and to 2 interventions - of which Multi-session telephone counseling is the first listed.
NCT00366977 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00366977 about?
NCT00366977 is a clinical study titled "Efficacy and Cost of State Quitline Policies". State-sponsored anti-tobacco campaigns are motivating large numbers of smokers to seek advice, assistance, and support to make their cessation efforts more successful. Like many states, Oregon has sponsored the implementation of a statewide telephone quitline to provide information, referrals, and c...
What is the current status of trial NCT00366977?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 4,614 participants. The study started on 2000-06. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00366977?
The interventions under investigation include: Multi-session telephone counseling (BEHAVIORAL), NRT patches (DRUG).
Who is sponsoring clinical trial NCT00366977?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00366977's enrollment target sits among peer trials
4,614 54th of 2000 higher than 1,947 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05768217 · 4,600 participants · NA
Community Resiliency Collective Efficacy Intervention
- NCT06535139 · 4,630 participants · NA
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
- NCT04371900 · 4,700 participants · NA
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
- NCT05486572 · 4,700 participants · NA
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia